Spring Bank Pharmaceuticals Inc

(No Reviews)
35 Parkwood Dr, Hopkinton, MA 01748, USA

Spring Bank Pharmaceuticals Inc is located in Middlesex County of Massachusetts state. On the street of Parkwood Drive and street number is 35. To communicate or ask something with the place, the Phone number is (508) 473-5993. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Spring Bank Pharmaceuticals Inc quickly are 42.2199281 ,-71.5455899

Contact and Address

Address: 35 Parkwood Dr, Hopkinton, MA 01748, USA
Postal code: 01748
Phone: (508) 473-5993
Website: https://springbankpharm.com/

Opening Hours:

Monday:8:30 AM – 5:00 PM
Tuesday:8:30 AM – 5:00 PM
Wednesday:8:30 AM – 5:00 PM
Thursday:8:30 AM – 5:00 PM
Friday:8:30 AM – 5:00 PM
Saturday:Closed
Sunday:Closed

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Spring Bank Pharmaceuticals Inc, use the form below and your opinion, advice or comment will appear in this space.

Write a Review

Photos of Spring Bank Pharmaceuticals Inc

Spring Bank Pharmaceuticals Inc | 35 Parkwood Dr, Hopkinton, MA 01748, USA | Phone: (508) 473-5993
Spring Bank Pharmaceuticals Inc | 35 Parkwood Dr, Hopkinton, MA 01748, USA | Phone: (508) 473-5993

Spring Bank Pharmaceuticals Inc On the Web

SBPH: Spring Bank Pharma Stock Price - Investing.com

Get today's Spring Bank Pharmaceuticals Inc stock price and latest SBPH news as well as Spring Bank Pharma real-time stock quotes, technical This is the main Spring Bank Pharmaceuticals Inc stock chart and current price. You can find more details by going to one of the sections under this...


Spring Bank Pharmaceuticals Inc | Hopkinton, MA... | Joesdata.com

Company & executive profile of Spring Bank Pharmaceuticals, Inc. in Hopkinton, MA with phone (508) 473-5993 & web www.springbankpharm.com. Business Description: Spring Bank Pharmaceuticals, Inc. is located at 86 South Street, Hopkinton, MA 01748.


Spring Bank Pharmaceuticals Inc. Stock Price (SBPH) | Barron's

View today's stock price, news and analysis for Spring Bank Pharmaceuticals Inc. (SBPH). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.


Spring Bank Pharmaceuticals Inc (SBPH.OQ) Quote| Reuters.com

Spring Bank Pharmaceuticals Inc (SBPH.OQ).


SBPH Stock Price Today - Spring Bank Pharmaceuticals Inc. Real...

Spring Bank Pharmaceuticals Inc. News. Spring Bank Pharma EPS beats by $0.28. Wednesday, July 31, 2019 02:11 PM. HOPKINTON, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing...


Spring Bank Pharmaceuticals Inc, SBPH:NAQ summary - FT.com

Key statistics. On Tuesday, Spring Bank Pharmaceuticals Inc (SBPH:NAQ) closed at 4.43, 23.74% above the 52 week low of 3.58 set on Jun 28, 2019. About the company. Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company.


SBPH - Spring Bank Pharmaceuticals Inc. • BioPharmCatalyst

ADMS Adamas Pharmaceuticals Inc. AERI Aerie Pharmaceuticals Inc. SBPH Spring Bank Pharmaceuticals Inc.


Spring Bank Pharmaceuticals Inc Information | Benzinga

Spring Bank Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of therapeutics using proprietary small molecule nucleic acid hybrid or SMNH, chemistry platform. These SMNH products can be used for the treatment of viral...


SPRING BANK PHARMACEUTICALS INC (SBPH)... | Stockopedia

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics using its small molecule nucleic acid hybrid (SMNH) chemistry platform. The Company is developing its SMNH product, SB 9200, for...


SBPH:NASDAQ CM Stock Quote - Spring Bank Pharmaceuticals Inc

Spring Bank Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company engages in the discovery and development of therapeutics for the treatment of viral infections. Spring Bank Pharmaceuticals conducts business in the United States.